Neurosphera Sp. z o.o.
- Address
- lock Available on a paid plan
Neurosphera Sp. z o.o. - Epilepsy Research Center
Neurosphera Sp. z o.o. is a specialized clinical research center focused on advancing treatment options for patients with neurological disorders, particularly complex seizure conditions. The center conducts pivotal clinical trials evaluating novel therapeutic approaches for patients who have not achieved adequate seizure control with existing medications.
- Refractory focal onset epilepsy treatment development
- Novel anticonvulsant drug efficacy and safety evaluation
- Adjunctive therapy optimization for treatment-resistant seizures
The research team specializes in evaluating adjunctive therapeutic interventions for patients with refractory focal onset epilepsy, focusing on clinically meaningful outcomes such as seizure frequency reduction. Their expertise includes conducting dose-optimization studies and assessing both the efficacy and safety profiles of investigational compounds in carefully selected patient populations who continue to experience seizures despite standard treatment regimens.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 6 by active trials.
- 1Biohaven Therapeutics Ltd.2active
lock +5 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Biohaven Therapeutics Ltd.4trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Neurosphera Sp. z o.o.
lock Showing 1 of 13 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3 Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Azetukalner as Adjunctive Therapy in Focal-Onset Seizures | Xenon Pharmaceuticals Inc. | Phase III | Not Recruiting | Aug 2023 | Jan 2026 |
IMP list
lock Showing 1 of 9 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bhv-7000 | 4 | Unknown | 2024-09-25 | 2024-12-18 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.